An open label follow on study to evaluate the long-term safety, tolerability and efficacy of ART621 following fortnightly administration for 48 weeks in patients with rheumatoid arthritis concomitantly taking methotrexate. An open label follow on study to evaluate the long-term safety, tolerability and efficacy of ART621f ...
An open label follow on study to evaluate the long-term safety, tolerability and efficacy of ART621 following fortnightly administration for 48 weeks in patients with rheumatoid arthritis concomitantly taking methotrexate. An open label follow on study to evaluate the long-term safety, tolerability and efficacy of ART621f ...
Dose Ranging Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate
Multi-Centre Randomised Double-Blind Pbo-Controlled Dose-Ranging Study to Evaluate the Safety, Tolerability, Efficacy, PK and Immunogenicity of Multiple Doses of ART621 for 3 Months in Patients With Rheumatoid Arthritis Taking Methotrexate Multi-Centre Randomised Double-Blind Pbo-Controlled Dose-Ranging Study to Evaluate the Safety, Toler ...
Rheumatoid Arthritis
Drug: ART621;Drug: Placebo
Arana Therapeutics Ltd
NULL
Terminated
18 Years
80 Years
Both
13
Phase 2
United States;Argentina;Australia;Czech Republic;India;Malaysia;New Zealand;Poland
A multi-centre randomised, double-blind, placebo-controlled, dose-ranging study to evaluate the safety, tolerability, efficacy, pharmacokinetics and immunogenicity of ART621 following multiple dose administration for 3 months in patients with rheumatoid arthritis concomitantly taking methotrexate A multi-centre randomised, double-blind, placebo-controlled, dose-ranging study to evaluate the safe ...
A multi-centre randomised, double-blind, placebo-controlled, dose-ranging study to evaluate the safety, tolerability, efficacy, pharmacokinetics and immunogenicity of ART621 following multiple dose administration for 3 months in patients with rheumatoid arthritis concomitantly taking methotrexate A multi-centre randomised, double-blind, placebo-controlled, dose-ranging study to evaluate the safe ...
Dose Optimisation Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate Dose Optimisation Study of ART621in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate ...
A Factorial-design, Randomised, Double-blind, Placebo-controlled, Dose Optimisation Study to Investigate the Safety, Efficacy, Immunogenicity and Pharmacokinetics of ART621 Following Multiple Dose Administration in Subjects Diagnosed With Rheumatoid Arthritis Concomitantly Taking Methotrexate A Factorial-design, Randomised, Double-blind, Placebo-controlled, Dose Optimisation Study to Investi ...